Protein Inhibitor May Bring A Topical Treatment For HPV
4/26/2011
Human papillomavirus (HPV) causes cervical cancer, the second most common cause of cancer death for women, and is a common cause of anogenital and some head and neck cancers. Thanks to research being done at Tufts University School of Medicine, patients infected with cancer-causing HPV may someday have an alternative to surgical and harsh chemical treatments...
FDA Approves Roche's HPV Test For Identifying Women At Highest Risk For Cervical Cancer
4/21/2011
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent many women from developing this deadly disease...
Breakthrough: Unique HPV Test To ID Cervical Cancer FDA Approved
4/20/2011
The only Food and Drug Administration (FDA) approved cervical cancer screening test that allows HPV 16 and 18 genotyping concurrently with high-risk HPV testing is now cleared for usage. These genotypes are responsible for 70% of all cervical cancer cases. The cobas HPV (Human Papillomavirus) Test identifies women at highest risk for developing cervical cancer...
Girls Failing To Complete HPV Vaccine Course, Australia
4/19/2011
Long-awaited data released by the Australian Government has raised concerns that many girls are failing to complete the three-dose course of the cervical cancer or human papillomavirus (HPV) vaccine...
Study Links Form Of Ovarian Cancer To Fallopian Tube
4/19/2011
High-grade serous ovarian cancer (HGSOC), the fifth-deadliest cancer among American women, is thought by many scientists to often be a fallopian tube malignancy masquerading as an ovarian one...
An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer cells and significantly increases survival in an ovarian cancer mouse model, a study at UCLA's Jonsson Comprehensive Cancer Center has found...
Safer-Sex Ed For Women Increases Condom Use, Might Reduce Partners
4/13/2011
Teaching young women how to prevent sexually transmitted infections (STIs) increases condom use and might reduce their number of sexual partners, but little research exists on whether educational programs reduce rates of STIs such as human papillomavirus, according to an updated research review from England. Human papillomavirus, or HPV, is the most common sexually transmitted infection...
Administration of human papillomavirus (HPV) vaccine doses over a longer period of time to adolescent girls in Vietnam resulted in antibody concentration levels that were comparable to the standard vaccine schedule, according to a study in the April 13 issue of JAMA, a theme issue on infectious disease and immunology. Kathleen M. Neuzil, M.D., M.P.H...
New Study Finds A Decrease In AIDS-Defining Cancers, Offset By An Increase In Other Cancers
4/12/2011
As treatments for HIV/AIDS improve and patients are living longer, the distribution of cancers in this population has undergone a dramatic shift in the United States. While cases of the types of cancer that have been associated with AIDS progression have decreased, cases of other types of cancer are on the rise...
Ovarian Cancer And At-Risk Women Who Wish To Have A Family
4/08/2011
Researchers at Oregon Health & Science University's Oregon National Primate Research Center may have good news for women at high-risk for ovarian cancer who also want to have children. The research suggests that a layer of cells, which serve as the "breeding ground" for ovarian cancer, may be removed yet allow the women to have children...